Pages that link to "Q33665968"
Jump to navigation
Jump to search
The following pages link to Thalamic damage and long-term progression of disability in multiple sclerosis. (Q33665968):
Displaying 50 items.
- The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects (Q26851476) (← links)
- Neuroimaging biomarkers of neurodegenerative diseases and dementia (Q27691820) (← links)
- A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives (Q28068709) (← links)
- Global and regional annual brain volume loss rates in physiological aging (Q30490628) (← links)
- Current and new directions in MRI in multiple sclerosis (Q30686331) (← links)
- DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis (Q30687549) (← links)
- Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. (Q30712257) (← links)
- Clinical relevance of brain volume measures in multiple sclerosis (Q30738659) (← links)
- Thalamus pathology in multiple sclerosis: from biology to clinical application. (Q30871067) (← links)
- Brain MRI atrophy quantification in MS: From methods to clinical application (Q31149648) (← links)
- Standardization of MRI data and disability quantification in the post-EPIC era. (Q31160516) (← links)
- Outcome Measures in Clinical Trials for Multiple Sclerosis. (Q31160866) (← links)
- Gray matter imaging in multiple sclerosis: what have we learned? (Q34094761) (← links)
- Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration (Q34303664) (← links)
- Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder. (Q34766860) (← links)
- Multimodal Quantitative Magnetic Resonance Imaging of Thalamic Development and Aging across the Human Lifespan: Implications to Neurodegeneration in Multiple Sclerosis (Q35593177) (← links)
- Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis (Q35672483) (← links)
- Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method (Q35888929) (← links)
- Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine (Q35997017) (← links)
- Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations (Q37002903) (← links)
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage (Q38444650) (← links)
- Neurodegeneration in multiple sclerosis and neuromyelitis optica (Q38965274) (← links)
- Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis (Q39069235) (← links)
- The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis. (Q41475478) (← links)
- Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. (Q42503511) (← links)
- Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis (Q42946025) (← links)
- Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS. (Q43807567) (← links)
- SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts (Q46861116) (← links)
- Tremor in multiple sclerosis is associated with cerebello-thalamic pathology. (Q47132200) (← links)
- Deep grey matter volume loss drives disability worsening in multiple sclerosis. (Q47866122) (← links)
- Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS. (Q47968702) (← links)
- Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality (Q47989756) (← links)
- Structural correlates for fatigue in early relapsing remitting multiple sclerosis (Q48081818) (← links)
- Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models (Q48127262) (← links)
- White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI. (Q48138904) (← links)
- Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden (Q48163868) (← links)
- Differential Impact of Multiple Sclerosis on Cortical and Deep Gray Matter Structures in African Americans and Caucasian Americans (Q48510335) (← links)
- The neurologist's dilemma: MS is a grey matter disease that standard clinical and MRI measures cannot assess adequately--no (Q48538975) (← links)
- Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis (Q48875299) (← links)
- A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients (Q48901292) (← links)
- Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease (Q49055426) (← links)
- Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis (Q52141693) (← links)
- Progression of regional grey matter atrophy in multiple sclerosis. (Q55362467) (← links)
- Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. (Q55502196) (← links)
- Thalamic Damage Predicts the Evolution of Primary-Progressive Multiple Sclerosis at 5 Years (Q57911768) (← links)
- Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis (Q64068104) (← links)
- The Relevance of Neuroimaging Findings to Physical Disability in Multiple Sclerosis. (Q64970467) (← links)
- Early perfusion changes in multiple sclerosis patients as assessed by MRI using arterial spin labeling (Q89457152) (← links)
- Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis (Q89630037) (← links)
- MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks? (Q90450400) (← links)